Interview: GSK's head of worldwide medical affairs, Danie du Plessis on rebuilding patient trust

16 March 2016

By Katie Osborne, in Barcelona

“Making sure the right patient gets the right treatment at the right time at the right dose is a mantra all pharmaceutical companies should adopt to ensure patients are at the centre of everything they do.”

That is the opinion of Danie du Plessis, senior vice president, head of worldwide medical affairs at GlaxoSmithKline (LSE: GSK), who was taking part in a panel debate on patient-centric leadership at the 14th annual eyeforpharma conference in Barcelona this week.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK